Previous Responders | Previous Non-Responders | |
---|---|---|
gFOB uptake in the 2nd invitation round | ||
Total | 86.55 (34 871) | 23.07 (23 677)†*** |
Women | 86.93 (18 777) | 23.86 (10 958) |
Men | 86.11 (16 094) | 22.39 (12 719) |
IMD 1st quintile | 88.35 (7646)‡ | 28.43 (4256)§ |
IMD 2nd quintile | 87.72 (7446) | 23.43 (4290) |
IMD 3rd quintile | 86.90 (7247) | 24.54 (4478) |
IMD 4th quintile | 86.01 (6732) | 22.17 (4926) |
IMD 5th quintile | 82.92 (5789) | 18.49 (5711) |
Age 62–63 at 2nd invitation¶ | 86.28 (17 810) | 22.34 (12 393) |
Age 64–65 at 2nd invitation | 87.03 (14 283) | 23.62 (9426) |
Age 66+ at 2nd invitation | 85.88 (2777) | 25.24 (1858) |
Multiple gFOB testing | ||
% Requiring one test only | 94.94 (30 241) | 92.52 (5532)†*** |
% Requiring multiple test kits | 5.06 (30 241) | 7.48 (5532)†*** |
% Inadequately screened | 0.20 (30 241) | 1.27 (5532)†*** |
FOB positivity | ||
Total | 1.50 (30 182) | 2.58 (5463)†*** |
Follow-up compliance | ||
Total | 90.27 (452) | 84.40 (141)† |
Diagnostic outcomes | ||
Cancers | 8.09 (408) | 9.24 (119)† |
High-risk and intermediate-risk adenomas | 27.73 (408) | 27.21 (119)† |
Low-risk adenomas | 17.40 (408) | 21.85 (119)† |
Other abnormal findings | 13.24 (408) | 22.69 (119)†* |
*p<0.05; ** p<0.01; *** p<0.001.
†Compared with previous responders.
‡IMD scores were not available for 11 individuals.
§IMD scores were not available for 16 individuals.
¶Includes 61-year-olds turning 62 in the same month (n=1), age missing for n=1.
gFOB, guaiac-based faecal occult blood; IMD, Index of Multiple Deprivation.